Developing tools for precise control of biological processes has been one of the main pillars of the now mature field of synthetic biology. These scientific tools borrow principles from a ...

Synthetic biology strives to achieve robust control of biological processes in order to create designer organisms for a variety of industrial, diagnostic, and therapeutic applications. Researchers ...

Alnylam Submits CTA Application for ALN-APP, an Investigational RNAi Therapeutic for the Treatment of Alzheimer’s Disease and Cerebral Amyloid Angiopathy ...

RNA origami enables applications in synthetic biology Date: October 5, 2022 Source: Aarhus University Summary: Synthetic biology strives to achieve robust control of biological processes in order ...

RNA interference (RNAi) is an ancient genetic regulatory mechanism that modern-day scientists are trying to harness. Since its discovery more than 10 years ago, RNAi R&D has run the gamut from ...

Alnylam has also formed Alnylam Biotherapeutics, a division of the company focused on the development of RNAi technologies for applications in biologics manufacturing, including recombinant ...

This can be useful for the development of RNA vaccines and therapeutics and for many other basic research applications, for instance, the investigation of RNA-protein interactions and generation of ...

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Company has submitted a Clinical Trial Authorization application to The Medicines and Healthcare ...

This cross-journal Collection welcomes articles that report on RNA-driven cellular mechanisms, physiologically relevant RNA processes, and the development and characterisation of novel RNA-based ...

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Company has submitted a Clinical Trial Authorization application to Health Canada to initiate a Phase ...

A Cornucopia of siRNA- and RNAi-based Therapeutics in Development Show Promise Researchers from academia and industry will present the latest developments in the application of interference RNA ...